Prakash Krishnan, MD, FACC, FSCAI
Dr. Prakash Krishnan of Icahn School of Medicine at Mount Sinai has a dual academic appointment as Assistant Professor of Medicine - Cardiology and Radiology. He also serves as the Director of Endovascular Interventions at The Mount Sinai Hospital's Cardiac Catheterization Laboratory and is Co-Director of the annual Live Symposium of Complex Coronary & Vascular Cases. In addition, he is the Director of Mount Sinai’s Peripheral Interventions Live Web Cast, a monthly interactive presentation of a complex endovascular case that is broadcasted live on the web teaching interventional cardiologists, interventional radiologists, and vascular surgeons around the world the latest data, approaches, and techniques in the management of peripheral arterial disease (PAD).
Dr. Krishnan has earned and maintained board certifications in the American Board of Internal Medicine in Internal Medicine, Cardiovascular Diseases, Interventional Cardiology, and Endovascular Interventions; and the State University of New York Medical License.
He is a Fellow of the American College of Cardiology (FACC), a well recognized leader in his field, and often invited to lecture at both national and international conferences.
MD, Rajah Muthaih Medical College
Residency, Internal Medicine
St. Vincent's CMC of NY
Ochsner Foundation Hospital
Fellowship, Interventional Cardiology
Mount Sinai Hospital
Fellowship, Interventional Cardiology
North Central Heart Institute
A Prospective, non-randomized, multi-center, clinical trial to evaluate the safety and efficacy of the Absolute Pro Peripheral self-expanding stent system in subjects with atherosclerotic de novo or restenotic lesions in the the native common iliac artery and/or native external iliac artery. (MOBILITY)
A Randomized, Open Label, Investigator-Initiated Trial comparing Intravascular Ultrasound-Guided Atherectomy to Angiography-Guided Atherectomy in Peripheral Vascular Interventions for TASC's A, B, C lesions. (UTOPIA trial)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Krishnan during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.